Throughline

Guidance ledger · Q4 FY26

Fortis Healthcare Limited FORTIS

4 revisions on record · 0 lowered · 4 raised — the strikethrough is what management used to say

gives specific guidance · held across quarters
↑ raised FY27 Hospital Revenue Growth Q3 FY26 → Q4 FY26
Qualitative (Q3FY26)15%+ (Q4FY26 explicit)
“revenue-wise, we are well poised to see on hospital side, 15% plus revenue growth.”
↑ raised FY27 Hospital EBITDA Margin Expansion Q3 FY26 → Q4 FY26
Qualitative 25% by FY28150 bps in FY27 (22.2% → 23.7%)
“EBITDA side, we expect another 150 basis point margin improvement for the current financial year.”
↑ raised 4-Year Brownfield Bed Plan Q3 FY26 → Q4 FY26
Project-specific FY27 (Q3FY26)1,800 beds 4-year + FY27 400+ beds explicit
“Over the next 4 years, we plan to ramp up bed capacity further through brownfield expansion by adding around 1,800 beds.”
↑ raised Annual Capex Q3 FY26 → Q4 FY26
~INR700cr FY26INR900cr/yr FY27 (60/40 maintenance/growth)
“we expect to incur around INR900 crores annually on the capex”

Method. Revisions come from management's own stated numbers, compared quarter over quarter across the covered concalls; each carries the verbatim quote. “No revisions” can also mean guidance too vague to pin down — see the posture chip above. Not investment advice.